Validation of a longitudinally measured surrogate marker for a time-to-event endpoint
From MaRDI portal
Publication:3591808
DOI10.1080/0266476022000023776zbMath1121.62475OpenAlexW1966558807WikidataQ59901747 ScholiaQ59901747MaRDI QIDQ3591808
Helena Geys, Luc Bijnens, Tomasz Burzykowski, Tony Vangeneugden, Marc Buyse, Geert Molenberghs, Didier Renard
Publication date: 11 September 2007
Published in: Journal of Applied Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/0266476022000023776
Related Items (7)
Center-within-trial versus trial-level evaluation of surrogate endpoints ⋮ Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints ⋮ Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy ⋮ Evaluation of longitudinal surrogate markers ⋮ A review on joint models in biometrical research ⋮ Statistical evaluation of surrogate endpoints with examples from cancer clinical trials ⋮ An information-theoretic approach to surrogate-marker evaluation with failure time endpoints
This page was built for publication: Validation of a longitudinally measured surrogate marker for a time-to-event endpoint
